Inotrem welcomes you at IBD Innovate 2023

IBD Innovate 2023 – April 26. 2023 (New York) – Inotrem welcomes you at IBD Innovate 2023, the annual one-day event organized by the Crohn’s & Colitis Foundation. Marc Derive, Inotrem’s Co-Founder & Chief Scientific Officer, is excited to share his presentation: “The Therapeutic Potential of Targeting TREM-1 and First Preclinical Data of Inotrem’s Second Asset INO-02 in Inflammatory Bowel Disease”. IBD Innovate is designed to advance product development along the IBD pipeline by fostering an exchange of ideas between researchers, companies, and funders. Inotrem actively collaborates with the Crohn and Colitis Foundation to develop a new promising anti-TREM-1 therapy in IBD.